- ICH GCP
- 미국 임상 시험 레지스트리
- 임상시험 NCT02813317
Optimizing the Care Pathways of Patients Treated for Operable Breast. (OPTIsoins01)
Optimizing the Care Pathways of Patients Treated for Operable Breast Cancer
연구 개요
상세 설명
The treatment course of a breast cancer patient includes a hospital stay, home health care that requires outpatient services, supportive care and a follow-up course. Outpatient surgery and home hospitalization units are two innovative organizational technologies that are strongly recommended because of their putative positive medico-economic impact; however, these structures are poorly studied in terms of quality of care and patient satisfaction. Regional implementation of these innovations is heterogeneous, thus allowing a comparative study.
This prospective, multicenter, observational study aims to explore a comprehensive approach to the care of early breast cancer patients in a regional health territory (including 1.5 million women and characterized by a breast cancer incidence and mortality higher than national ranges), incorporating all healthcare actors inside and outside the hospital.
This study will be conducted in academic centers, general hospitals and private centers. In the different participating centers, the implemented care steps are different and may include outpatient surgery, home hospitalization, a one-stop breast clinic visit, care by an oncology pivot nurse and/or screening for supportive care. Outpatient surgery and home hospitalization in particular are two health technologies that are validated by the French National Authority for Health but used differently in different centers.
The primary objective is to examine the economic and financial measurements of the different care pathways of early breast cancer patients to compare the economic burden of outpatient surgery and home hospitalization with the conventional care pathway.
The secondary objectives are:
Assessing patient satisfaction and needs for supportive care. Evaluating the structures and organizations. Evaluating the tool exchanges between the actors over the treatment course.
All parameters related to the patient and to disease characteristics, determinants and management characteristics within and outside the center within one year will be collected and centralized in the study database. The patients' course of care will be divided into five stages: preadmission, hospitalization, the postoperative period (+ 1 month), adjuvant treatments and one-year follow-up. Care pathways will be identified, described and analyzed to meet the primary objective and the secondary objectives.
After analyzing these care pathways, we will propose solutions for optimizing hospital and nonhospital care, thereby building efficient connections among the hospital, home health care, district nurse networks, medical and social sectors, and occupational reintegration.
연구 유형
등록 (실제)
연락처 및 위치
연구 장소
-
-
-
Argenteuil, 프랑스, 95100
- Victor Dupouy Hospital
-
Clamart, 프랑스
- Antoine Beclère Hospital
-
Colombes, 프랑스, 92700
- Louis Mourier Hospital
-
Le Chesnay, 프랑스, 78150
- André Mignot Hospital - Versailles
-
Paris, 프랑스, 75005
- Institut Curie
-
Paris, 프랑스, 75018
- Bichat Beaujon University Hospital
-
Poissy, 프랑스, 78300
- Poissy Interegional Hospital Center
-
Pontoise, 프랑스, 95000
- Rene Dubos Hospital
-
Saint-Cloud, 프랑스, 92210
- Institut Curie - René Huguenin Hospital
-
-
참여기준
자격 기준
공부할 수 있는 나이
건강한 자원 봉사자를 받아들입니다
연구 대상 성별
샘플링 방법
연구 인구
설명
Inclusion Criteria:
- Signed written informed consent.
- Patients aged ≥18 years.
- Previously untreated, operable breast cancer
- Affiliation with the social security system (or a similar coverage)
- Patient living in one of these french department : "Hauts-de-Seine (92)", "les Yvelines (78)", or "le Val d'Oise (95)".
- Female gender.
Exclusion Criteria:
- Previous history of breast cancer.
- Metastatic, locally advanced, or inflammatory breast cancer, as defined by the AJCC (American Joint Committee on Cancer, 7th Edition).
- Any prior treatment for primary breast cancer.
- Patient with any psychological, sociological or geographical condition potentially hampering compliance with the study follow-up schedule.
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
- 관찰 모델: 보병대
- 시간 관점: 유망한
연구는 무엇을 측정합니까?
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
---|---|---|
Care pathways description of early breast cancer patients.
기간: Up to one year after patient registration
|
Care pathways will be characterized by the sequence of different care steps.
Care steps may include : outpatient surgery, home hospitalization, a one-stop breast clinic visit, care by an oncology pivot nurse and/or screening for supportive care.
|
Up to one year after patient registration
|
Overall cost measurements of the different care pathways.
기간: Up to one year after patient registration
|
Evaluating the overall costs of the pathway care (health care and supportive care consumption) at one year for the different perspectives.
|
Up to one year after patient registration
|
Overall cost measurements of the different care pathways for health insurance
기간: Up to one year after patient registration
|
Evaluating the indirect costs of health insurance
|
Up to one year after patient registration
|
Overall cost measurements of the different care pathways for the patient
기간: Up to one year after patient registration
|
Evaluating the out-of-pocket health expenses for breast cancer during the first year post diagnosis (direct and indirect costs).
|
Up to one year after patient registration
|
2차 결과 측정
결과 측정 |
측정값 설명 |
기간 |
---|---|---|
Patient satisfaction evaluation
기간: Up to one year after patient registration.
|
Patient satisfaction will be assessed at different time points using the OUT-PATSAT35 questionnaire validated in French.
|
Up to one year after patient registration.
|
Supportive care needs assessement
기간: Up to one year after patient registration
|
The patient's needs for supportive care will be assessed using the Supportive Care Needs Survey - Breast Cancer module (SCNS-BR8) validated in French.
|
Up to one year after patient registration
|
Supportive care needs assessement
기간: Up to one year after patient registration
|
The patient's needs for supportive care will be assessed using the Supportive Care Needs Survey Short Form (SCNS-SF34) validated in French.
|
Up to one year after patient registration
|
Breast cancer impact on patient's professional activity
기간: Up to one year after patient registration.
|
Evaluating patient return to work : Existence of an occupational reintegration or not.
|
Up to one year after patient registration.
|
Breast cancer impact on patient's professional activity
기간: Up to one year after patient registration.
|
Evaluating patient return to work : Date of return to work
|
Up to one year after patient registration.
|
Breast cancer impact on patient's professional activity
기간: Up to one year after patient registration.
|
Evaluating patient return to work : Organization of working time description
|
Up to one year after patient registration.
|
Breast cancer impact on patient's professional activity
기간: Up to one year after patient registration.
|
Evaluating patient return to work : Number of days out of work
|
Up to one year after patient registration.
|
Structures and organizations interactions description
기간: Up to one year after patient registration
|
Identification of health care actors inside and outside the hospital
|
Up to one year after patient registration
|
Structures and organizations interactions description
기간: Up to one year after patient registration
|
identification of the interactions between the organizations (e.g., identification, shared tools, resource sharing and nurse training).
|
Up to one year after patient registration
|
Structures and organizations interactions description
기간: Up to one year after patient registration
|
Regular practitioners questionnaires
|
Up to one year after patient registration
|
기타 결과 측정
결과 측정 |
측정값 설명 |
기간 |
---|---|---|
Care pathways suggestion for a regional health territory.
기간: Through study completion (within one year after the last patient follow-up)
|
After analyzing these care pathways, we will propose solutions for optimizing hospital and nonhospital care, thereby building efficient connections among the hospital, home health care, district nurse networks, medical and social sectors, and occupational reintegration.
|
Through study completion (within one year after the last patient follow-up)
|
공동 작업자 및 조사자
스폰서
수사관
- 연구 책임자: Roman ROUZIER, Pr, Institut Curie
- 연구 책임자: Delphine HEQUET, MD PhD, Institut Curie
간행물 및 유용한 링크
연구 기록 날짜
연구 주요 날짜
연구 시작 (실제)
기본 완료 (실제)
연구 완료 (실제)
연구 등록 날짜
최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (추정)
연구 기록 업데이트
마지막 업데이트 게시됨 (실제)
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
추가 정보
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .
유방암에 대한 임상 시험
-
Georgetown UniversityNational Cancer Institute (NCI); American Cancer Society, Inc.; Susan G. Komen Breast Cancer...완전한
-
University of UtahNational Cancer Institute (NCI)모병피로 | 좌식 생활 | 전이성 전립선암 | IV기 전립선암 AJCC(American Joint Committee on Cancer) v8 | IVA기 전립선암 AJCC(American Joint Committee on Cancer) v8 | IVB기 전립선암 AJCC(American Joint Committee on Cancer) v8미국
-
Jonsson Comprehensive Cancer Center아직 모집하지 않음전립선암 | IVB기 전립선암 American Joint Committee on Cancer(AJCC) v8미국
-
Rashmi Verma, MDNational Cancer Institute (NCI)모병거세저항성 전립선암 | 전이성 전립선 선암종 | IVB기 전립선암 American Joint Committee on Cancer(AJCC) v8미국
-
Jonsson Comprehensive Cancer Center빼는전립선 선암종 | 2기 전립선암 AJCC v8 | IIC기 전립선암 AJCC v8 | IIA기 전립선암 AJCC v8 | IIB기 전립선암 AJCC v8 | 1기 전립선암 American Joint Committee on Cancer(AJCC) v8미국
-
Jonsson Comprehensive Cancer CenterMiraDX모집하지 않고 적극적으로전립선 선암종 | 2기 전립선암 AJCC v8 | IIC기 전립선암 AJCC v8 | IIA기 전립선암 AJCC v8 | IIB기 전립선암 AJCC v8 | 1기 전립선암 American Joint Committee on Cancer(AJCC) v8미국
-
Jonsson Comprehensive Cancer Center종료됨거세저항성 전립선암 | 전이성 전립선암 | IVA기 전립선암 AJCC v8 | IVB기 전립선암 AJCC v8 | IV기 전립선암 American Joint Committee on Cancer(AJCC) v8미국
-
Assiut University아직 모집하지 않음South Egypt Cancer Institute(SECI)에서 소아 악성종양 환자에 대한 KDIGO 기준을 사용하여 AKI의 누적 발병률을 확인하기 위해
-
Jonsson Comprehensive Cancer CenterNational Cancer Institute (NCI)모집하지 않고 적극적으로III기 전립선 선암종 AJCC v7 | II기 전립선 선암종 AJCC v7 | 1기 전립선 선암종 American Joint Committee on Cancer(AJCC) v7미국